Share:
Peer-Reviewed Publication
Am J Public Health2026;116(S3):S152-S161.July 1, 2026Journal Article

Assessing Cardiovascular Disease Prevention Activities in the Denver, Colorado, Metropolitan Area: Building on an Existing Network to Enhance Emphasis on Equity.

Meredith P Fort1, Krista A Haapanen1, Aina Aulakh1, Jennifer Moreland1, Tristan Sanders1, Mouna Dardouri1, Kyla L Bauer1, Elena Broaddus-Shea1, Russell E Glasgow1, Glen P Mays1, Shiriki Kumanyika1, Kamal Henderson1
1At the time of the study, Meredith P. Fort, Aina Aulakh, Kyla L. Bauer, Mouna Dardouri, and Glen P. Mays were with the Department of Health Systems, Management and Policy, University of Colorado - Anschutz, Aurora, CO. Krista A. Haapanen is with the Department of Psychology, University of Hawai'i Mānoa, Honolulu. Jennifer Moreland is with the Public Health Institute at Denver Health, Denver, CO. Tristan Sanders is with the Denver Department of Public Health and Environment, Denver, CO. Elena Broaddus-Shea and Russell E. Glasgow are with the Department of Family Medicine, University of Colorado Anschutz. Shiriki Kumanyika was with the Department of Community Health and Prevention, Drexel University, Philadelphia, PA. Kamal Henderson was with the Division of Cardiology, School of Medicine, University of Colorado Anschutz.

Abstract

Objectives. To summarize and present a visual representation of the complex implementation context of cardiovascular disease prevention interventions and identify opportunities to increase an emphasis on equity. Methods. From May to October 2021, we conducted 24 interviews with people knowledgeable about cardiovascular disease prevention activities in the Denver, Colorado, metropolitan area, guide…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.